Exploring the supraspinal antihyperalgesic effects of levetiracetam in the rat model of chronic constriction injury
Canadian Journal of Physiology and Pharmacology · 2025
DOI: 10.1139/cjpp-2024-0302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2025. Verfasst von Feyza Alyu Altinok und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Anadolu University, 26470 Eskisehir, Turkey. Hauptthemen laut MEDLINE: Levetiracetam, Hyperalgesia, Neuralgia, Analgesics. Die Arbeit nennt 69 Literaturangaben. Gefördert von: European Molecular Biology Organization, Anadolu University Scientific Research Projects Commission.
Abstract (Originalsprache)
Neuropathic pain severely impacts quality of life and effective treatments are needed. To address this, the present study investigated the antihyperalgesic mechanisms of levetiracetam administered at the supraspinal level, together with its effects on ion channel activities. The ventral posterolateral nucleus of the thalamus was selected as the location for micro-injection. Thermal hyperalgesia and mechanical allodynia were assessed via in vivo experiments using the Hargreave’s and e-Von Frey apparatus, respectively. Levetiracetam displayed statistically meaningful time and dose-dependent effects in the chronic constriction injury model, with statistical probability values less than 0.05. It was discovered that the antihyperalgesic effects were more pronounced in mechanical allodynia. Electrophysiological studies conducted through whole-cell patch clamp recordings indicated that levetiracetam tended to activate or increase the permeability of one or more channels for ion flow that are active only at hyperpolarized membrane potentials (−130 to −90 mV), suggesting the potential participation of hyperpolarization-activated cyclic nucleotide–gated, inwardly-rectifying K + , or G protein-gated inwardly-rectifying K + channels. The findings could guide future drug development studies towards levetiracetam and its derivatives as effective treatments for neuropathic pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Pharmacy, Anadolu University, 26470 Eskisehir, Turkey.
- Department of Pharmacological Sciences and Experimental Medicine, University of Camerino, 62032 Camerino, Italy.
- Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, S-581 85, Linköping, Sweden.
- Department of Neuroscience, Psychology, Drug Research and Child's Health, NEUROFARBA, Università di Firenze, 50139 Firenze, Italy.
- Department of Pharmacology, Faculty of Pharmacy, Istanbul Aydin University, 34295 Istanbul, Turkey.
ORCID-Profile: Feyza Alyu Altinok
Förderung
- European Molecular Biology Organization
- Anadolu University Scientific Research Projects Commission
Zitieren
APA
Altinok, F., Petrella, M., Masi, A., Borruto, A., Ciccocioppo, R., & Ozturk, Y. (2025). Exploring the supraspinal antihyperalgesic effects of levetiracetam in the rat model of chronic constriction injury. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2024-0302
Vancouver
Altinok F, Petrella M, Masi A, Borruto A, Ciccocioppo R, Ozturk Y. Exploring the supraspinal antihyperalgesic effects of levetiracetam in the rat model of chronic constriction injury. Canadian Journal of Physiology and Pharmacology. 2025. doi:10.1139/cjpp-2024-0302
BibTeX
@article{Altinok2025,
author = {Altinok, Feyza Alyu and Petrella, Michele and Masi, Alessio and Borruto, Anna Maria and Ciccocioppo, Roberto and Ozturk, Yusuf},
title = {Exploring the supraspinal antihyperalgesic effects of levetiracetam in the rat model of chronic constriction injury},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2025},
doi = {10.1139/cjpp-2024-0302}
}
EUVIMED